Kezar Life Sciences, Inc. IPO Research Information

Kezar Life Sciences, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Kezar Life Sciences, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Kezar Life Sciences, Inc.	KZR - NASDAQ	$14.00-$16.00	$15.00	$20.00	5 million	6/21/2018
Underwriter(s): Jefferies, Cowen, Wells Fargo, William Blair
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2018-05-24 Terms Added 2018-06-08

Kezar Life Sciences, Inc. Quote & Chart - Click for current quote - KZR

About Kezar Life Sciences, Inc. (adapted from Kezar Life Sciences, Inc. prospectus):
They are a clinical-stage biotechnology company, discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "KZR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.